Distinct responses of lung and liver macrophages to acute endotoxemia. Role of toll-like receptor 4.

Experimental and Molecular Pathology

Volumn 94, Issue 1, 2013, Pages 216-227

  Connor, Agnieszka J ^a   Chen, Li C ^a   Joseph, Laurie B ^a   Laskin, Jeffrey D ^b   Laskin, Debra L ^a  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Inflammation; Liver; LPS; Lung; Macrophages; TLR4

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; COMPLEMENTARY DNA; CYCLINE; CYCLOOXYGENASE 2; HEME OXYGENASE 1; ICOSANOID; INDUCIBLE NITRIC OXIDE SYNTHASE; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTOXEMIA; IMMUNOHISTOCHEMISTRY; LIVER MACROPHAGE; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; ARACHIDONATE 12-LIPOXYGENASE; ARACHIDONATE 15-LIPOXYGENASE; CYCLOOXYGENASE 2; ENDOTOXEMIA; ENZYME ACTIVATION; HEME OXYGENASE-1; INTRAMOLECULAR OXIDOREDUCTASES; KUPFFER CELLS; LIPOPOLYSACCHARIDES; LIVER; LUNG; MACROPHAGES, ALVEOLAR; MALE; MICE; MICE, INBRED C3H; MICE, TRANSGENIC; PROLIFERATING CELL NUCLEAR ANTIGEN; RNA, MESSENGER; SUPEROXIDE DISMUTASE; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

BACTERIA (MICROORGANISMS); MUS;

EID: 84871010437     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2012.09.006     Document Type: Article

References (65)

1. Abel B., Thieblemont N., Quesniaux V.J., Brown N., Mpagi J., Miyake K., Bihl F., Ryffel B. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. The Journal of Immunology 2002, 169:3155-3162.
2. Ahmad N., Chen L.C., Gordon M.A., Laskin J.D., Laskin D.L. Regulation of cyclooxygenase-2 by nitric oxide in activated hepatic macrophages during acute endotoxemia. Journal of Leukocyte Biology 2002, 71:1005-1011.
3. Akira S., Takeda K. Toll-like receptor signalling. Nature Reviews. Immunology 2004, 4:499-511.
4. Annane D., Bellissant E., Cavaillon J.M. Septic shock. Lancet 2005, 365:63-78.
5. Chen L.C., Gordon R.E., Laskin J.D., Laskin D.L. Role of TLR-4 in liver macrophage and endothelial cell responsiveness during acute endotoxemia. Experimental and Molecular Pathology 2007, 83:311-326.
6. Ciesla D.J., Moore E.E., Johnson J.L., Burch J.M., Cothren C.C., Sauaia A. The role of the lung in postinjury multiple organ failure. Surgery 2005, 138:749-757.
7. Connor A.J., Laskin J.D., Laskin D.L. Ozone-induced lung injury and sterile inflammation. Role of toll-like receptor 4. Experimental and Molecular Pathology 2012, 92:229-235.
8. Coqueret O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment?. Trends in Cell Biology 2003, 13:65-70.
9. Davies L.C., Rosas M., Smith P.J., Fraser D.J., Jones S.A., Taylor P.R. A quantifiable proliferative burst of tissue macrophages restores homeostatic macrophage populations after acute inflammation. European Journal of Immunology 2011, 41:2155-2164.
10. Fan J., Kapus A., Marsden P.A., Li Y.H., Oreopoulos G., Marshall J.C., Frantz S., Kelly R.A., Medzhitov R., Rotstein O.D. Regulation of toll-like receptor 4 expression in the lung following hemorrhagic shock and lipopolysaccharide. The Journal of Immunology 2002, 168:5252-5259.
11. Feder L.S., Laskin D.L. Regulation of hepatic endothelial cell and macrophage proliferation and nitric oxide production by GM-CSF, M-CSF, and IL-1 beta following acute endotoxemia. Journal of Leukocyte Biology 1994, 55:507-513.
12. Fehrenbach H. Alveolar epithelial type II cell: defender of the alveolus revisited. Respiratory Research 2001, 2:33-46.
13. Fry D.E. Sepsis, systemic inflammatory response, and multiple organ dysfunction: the mystery continues. The American Surgeon 2012, 78:1-8.
14. Funk C.D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 2001, 294:1871-1875.
15. Gardner C.R., Gray J.P., Joseph L.B., Cervelli J., Bremer N., Kim Y., Mishin V., Laskin J.D., Laskin D.L. Potential role of caveolin-1 in acetaminophen-induced hepatotoxicity. Toxicology and Applied Pharmacology 2010, 245:36-46.
16. Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity. Nature Reviews. Immunology 2005, 5:953-964.
17. Guo J., Loke J., Zheng F., Hong F., Yea S., Fukata M., Tarocchi M., Abar O.T., Huang H., Sninsky J.J., Friedman S.L. Functional linkage of cirrhosis-predictive single nucleotide polymorphisms of Toll-like receptor 4 to hepatic stellate cell responses. Hepatology 2009, 49:960-968.
18. Hollingsworth J.W., Chen B.J., Brass D.M., Berman K., Gunn M.D., Cook D.N., Schwartz D.A. The critical role of hematopoietic cells in lipopolysaccharide-induced airway inflammation. American Journal of Respiratory and Critical Care Medicine 2005, 171:806-813.
19. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K., Akira S. Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. The Journal of Immunology 1999, 162:3749-3752.
20. Isbel N.M., Hill P.A., Foti R., Mu W., Hurst L.A., Stambe C., Lan H.Y., Atkins R.C., Nikolic-Paterson D.J. Tubules are the major site of M-CSF production in experimental kidney disease: correlation with local macrophage proliferation. Kidney International 2001, 60:614-625.
21. Jiang W., Sun R., Wei H., Tian Z. Toll-like receptor 3 ligand attenuates LPS-induced liver injury by down-regulation of toll-like receptor 4 expression on macrophages. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:17077-17082.
22. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nature Immunology 2010, 11:373-384.
23. Kinnula V.L., Crapo J.D. Superoxide dismutases in the lung and human lung diseases. American Journal of Respiratory and Critical Care Medicine 2003, 167:1600-1619.
24. Kumpers P., Hafer C., Lukasz A., Lichtinghagen R., Brand K., Fliser D., Faulhaber-Walter R., Kielstein J.T. Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury. Critical Care 2010, 14:R9.
25. Laskin D.L., Sunil V.R., Gardner C.R., Laskin J.D. Macrophages and tissue injury: agents of defense or destruction?. Annual Review of Pharmacology and Toxicology 2011, 51:267-288.
26. Levy B.D., Clish C.B., Schmidt B., Gronert K., Serhan C.N. Lipid mediator class switching during acute inflammation: signals in resolution. Nature Immunology 2001, 2:612-619.
27. Lin Q., Li M., Fang D., Fang J., Su S.B. The essential roles of toll-like receptor signaling pathways in sterile inflammatory diseases. International Immunopharmacology 2011, 11:1422-1432.
28. Lloberas J., Celada A. p21(waf1/CIP1), a CDK inhibitor and a negative feedback system that controls macrophage activation. European Journal of Immunology 2009, 39:691-694.
29. Mandal P., Roychowdhury S., Park P.H., Pratt B.T., Roger T., Nagy L.E. Adiponectin and heme oxygenase-1 suppress TLR4/MyD88-independent signaling in rat Kupffer cells and in mice after chronic ethanol exposure. The Journal of Immunology 2010, 185:4928-4937.
30. Maris N.A., Dessing M.C., de Vos A.F., Bresser P., van der Zee J.S., Jansen H.M., Spek C.A., van der Poll T. Toll-like receptor mRNA levels in alveolar macrophages after inhalation of endotoxin. The European Respiratory Journal 2006, 28:622-626.
31. Matzinger P. The danger model: a renewed sense of self. Science 2002, 296:301-305.
32. Matzinger P., Kamala T. Tissue-based class control: the other side of tolerance. Nature Reviews. Immunology 2011, 11:221-230.
33. McCloskey T.W., Todaro J.A., Laskin D.L. Lipopolysaccharide treatment of rats alters antigen expression and oxidative metabolism in hepatic macrophages and endothelial cells. Hepatology 1992, 16:191-203.
34. Miller S.I., Ernst R.K., Bader M.W. LPS, TLR4 and infectious disease diversity. Nature Reviews. Microbiology 2005, 3:36-46.
35. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nature Reviews. Immunology 2008, 8:958-969.
36. Murray P.J., Wynn T.A. Protective and pathogenic functions of macrophage subsets. Nature Reviews. Immunology 2011, 11:723-737.
37. Nakata K., Gotoh H., Watanabe J., Uetake T., Komuro I., Yuasa K., Watanabe S., Ieki R., Sakamaki H., Akiyama H., Kudoh S., Naitoh M., Satoh H., Shimada K. Augmented proliferation of human alveolar macrophages after allogeneic bone marrow transplantation. Blood 1999, 93:667-673.
38. Ostuni R., Natoli G. Transcriptional control of macrophage diversity and specialization. European Journal of Immunology 2011, 41:2486-2490.
39. Paine A., Eiz-Vesper B., Blasczyk R., Immenschuh S. Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochemical Pharmacology 2010, 80:1895-1903.
40. Pilaro A.M., Laskin D.L. Accumulation of activated mononuclear phagocytes in the liver following lipopolysaccharide treatment of rats. Journal of Leukocyte Biology 1986, 40:29-41.
41. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282:2085-2088.
42. Protzer U., Maini M.K., Knolle P.A. Living in the liver: hepatic infections. Nature Reviews. Immunology 2012, 12:201-213.
43. Punjabi C.J., Laskin J.D., Pendino K.J., Goller N.L., Durham S.K., Laskin D.L. Production of nitric oxide by rat type II pneumocytes: increased expression of inducible nitric oxide synthase following inhalation of a pulmonary irritant. American Journal of Respiratory Cell and Molecular Biology 1994, 11:165-172.
44. Qin L., Wu X., Block M.L., Liu Y., Breese G.R., Hong J.S., Knapp D.J., Crews F.T. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 2007, 55:453-462.
45. Raetz C.R., Whitfield C. Lipopolysaccharide endotoxins. Annual Review of Biochemistry 2002, 71:635-700.
46. Roger T., Froidevaux C., Le Roy D., Reymond M.K., Chanson A.L., Mauri D., Burns K., Riederer B.M., Akira S., Calandra T. Protection from lethal gram-negative bacterial sepsis by targeting toll-like receptor 4. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:2348-2352.
47. Rojas M., Woods C.R., Mora A.L., Xu J., Brigham K.L. Endotoxin-induced lung injury in mice: structural, functional, and biochemical responses. American Journal of Physiology. Lung Cellular and Molecular Physiology 2005, 288:L333-L341.
48. Scatizzi J.C., Mavers M., Hutcheson J., Young B., Shi B., Pope R.M., Ruderman E.M., Samways D.S., Corbett J.A., Egan T.M., Perlman H. The CDK domain of p21 is a suppressor of IL-1beta-mediated inflammation in activated macrophages. European Journal of Immunology 2009, 39:820-825.
49. Schulte J., Struck J., Kohrle J., Muller B. Circulating levels of peroxiredoxin 4 as a novel biomarker of oxidative stress in patients with sepsis. Shock 2011, 35:460-465.
50. Schumann R.R., Leong S.R., Flaggs G.W., Gray P.W., Wright S.D., Mathison J.C., Tobias P.S., Ulevitch R.J. Structure and function of lipopolysaccharide binding protein. Science 1990, 249:1429-1431.
51. Serhan C.N., Chiang N., Van Dyke T.E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nature Reviews. Immunology 2008, 8:349-361.
52. Sunil V.R., Connor A.J., Guo Y., Laskin J.D., Laskin D.L. Activation of type II alveolar epithelial cells during acute endotoxemia. American Journal of Physiology. Lung Cellular and Molecular Physiology 2002, 282:L872-L880.
53. Sunil V.R., Patel K.J., Nilsen-Hamilton M., Heck D.E., Laskin J.D., Laskin D.L. Acute endotoxemia is associated with upregulation of lipocalin 24p3/Lcn2 in lung and liver. Experimental and Molecular Pathology 2007, 83:177-187.
54. Trakala M., Arias C.F., Garcia M.I., Moreno-Ortiz M.C., Tsilingiri K., Fernandez P.J., Mellado M., Diaz-Meco M.T., Moscat J., Serrano M., Martinez A.C., Balomenos D. Regulation of macrophage activation and septic shock susceptibility via p21(WAF1/CIP1). European Journal of Immunology 2009, 39:810-819.
55. Trebino C.E., Eskra J.D., Wachtmann T.S., Perez J.R., Carty T.J., Audoly L.P. Redirection of eicosanoid metabolism in mPGES-1-deficient macrophages. The Journal of Biological Chemistry 2005, 280:16579-16585.
56. Uderhardt S., Herrmann M., Oskolkova O.V., Aschermann S., Bicker W., Ipseiz N., Sarter K., Frey B., Rothe T., Voll R., Nimmerjahn F., Bochkov V.N., Schett G., Kronke G. 12/15-lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunologic tolerance. Immunity 2012, 36:834-846.
57. Vadiveloo P.K. Macrophages-proliferation, activation, and cell cycle proteins. Journal of Leukocyte Biology 1999, 66:579-582.
58. Vazquez-Torres A., Vallance B.A., Bergman M.A., Finlay B.B., Cookson B.T., Jones-Carson J., Fang F.C. Toll-like receptor 4 dependence of innate and adaptive immunity to Salmonella: importance of the Kupffer cell network. The Journal of Immunology 2004, 172:6202-6208.
59. Ware L.B., Fessel J.P., May A.K., Roberts L.J. Plasma biomarkers of oxidant stress and development of organ failure in severe sepsis. Shock 2011, 36:12-17.
60. Weis N., Weigert A., von Knethen A., Brune B. Heme oxygenase-1 contributes to an alternative macrophage activation profile induced by apoptotic cell supernatants. Molecular Biology of the Cell 2009, 20:1280-1288.
61. Wittebole X., Castanares-Zapatero D., Laterre P.F. Toll-like receptor 4 modulation as a strategy to treat sepsis. Mediators of Inflammation 2010, 2010:568396.
62. Wizemann T.M., Laskin D.L. Enhanced phagocytosis, chemotaxis, and production of reactive oxygen intermediates by interstitial lung macrophages following acute endotoxemia. American Journal of Respiratory Cell and Molecular Biology 1994, 11:358-365.
63. Wohl S.G., Schmeer C.W., Witte O.W., Isenmann S. Proliferative response of microglia and macrophages in the adult mouse eye after optic nerve lesion. Investigative Ophthalmology and Visual Science 2010, 51:2686-2696.
64. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990, 249:1431-1433.
65. Xu Y., Chen J., Yu X., Tao W., Jiang F., Yin Z., Liu C. Protective effects of chlorogenic acid on acute hepatotoxicity induced by lipopolysaccharide in mice. Inflammation Research 2010, 59:871-877.